Enhanced CXCR4 Expression of Human CD8Low T Lymphocytes Is Driven by S1P4

Front Immunol. 2021 Aug 24:12:668884. doi: 10.3389/fimmu.2021.668884. eCollection 2021.

Abstract

Although the human immune response to cancer is naturally potent, it can be severely disrupted as a result of an immunosuppressive tumor microenvironment. Infiltrating regulatory T lymphocytes contribute to this immunosuppression by inhibiting proliferation of cytotoxic CD8+ T lymphocytes, which are key to an effective anti-cancer immune response. Other important contributory factors are thought to include metabolic stress caused by the local nutrient deprivation common to many solid tumors. Interleukin-33 (IL-33), an alarmin released in reaction to cell damage, and sphingosine-1-phosphate (S1P) are known to control cell positioning and differentiation of T lymphocytes. In an in vitro model of nutrient deprivation, we investigated the influence of IL-33 and S1P receptor 4 (S1P4) on the differentiation and migration of human CD8+ T lymphocytes. Serum starvation of CD8+ T lymphocytes induced a subset of CD8Low and IL-33 receptor-positive (ST2L+) cells characterized by enhanced expression of the regulatory T cell markers CD38 and CD39. Both S1P1 and S1P4 were transcriptionally regulated after stimulation with IL-33. Moreover, expression of the chemokine receptor CXCR4 was increased in CD8+ T lymphocytes treated with the selective S1P4 receptor agonist CYM50308. We conclude that nutrient deprivation promotes CD8Low T lymphocytes, contributing to an immunosuppressive microenvironment and a poor anti-cancer immune response by limiting cytotoxic effector functions. Our results suggest that S1P4 signaling modulation may be a promising target for anti-CXCR4 cancer immunotherapy.

Keywords: IL-33; chemokines; cytotoxic T lymphocyte; sphingolipids; tumor immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / metabolism
  • Apyrase / metabolism
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism*
  • Cell Differentiation
  • Cell Movement
  • Cells, Cultured
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein / metabolism
  • Interleukin-33 / pharmacology
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / metabolism*
  • Membrane Glycoproteins / metabolism
  • Phenotype
  • Programmed Cell Death 1 Receptor / metabolism
  • Receptors, CXCR4 / genetics
  • Receptors, CXCR4 / metabolism*
  • Signal Transduction
  • Sphingosine-1-Phosphate Receptors / agonists
  • Sphingosine-1-Phosphate Receptors / genetics
  • Sphingosine-1-Phosphate Receptors / metabolism*
  • Tumor Microenvironment* / immunology
  • Up-Regulation

Substances

  • CXCR4 protein, human
  • IL1RL1 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Interleukin-33
  • Membrane Glycoproteins
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Receptors, CXCR4
  • S1PR1 protein, human
  • S1PR4 protein, human
  • Sphingosine-1-Phosphate Receptors
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1
  • Apyrase
  • ENTPD1 protein, human